Since its approval for the treatment of medical refractory epilepsy in 2013, the closed-loop neuromodulation device has had its efficacy and safety confirmed in several pivotal studies and will now be assessed in focal epilepsy in the RESPONSE trial.
When an infant presents with fractures that suggest possible abuse, but appears to be neurologically fine, clinicians should make sure to rule out occult head injury. A report looks at whether many children’s hospitals are routinely following this guidance.
A clinical trial can offer a child a chance for relief from painful headaches. An investigation examines whether the benefits of treatment in a migraine study were sustained, even after treatment ended.